Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) Other Stockholders Equity: ₺551 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ORZAX Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
18 GF Score
Price ₺87.50
! 3 Warning Signs
View Full Analysis

What is Orzaks Ilac Ve Kimyanayi Ticaret AS Other Stockholders Equity?

Orzaks Ilac Ve Kimyanayi Ticaret AS IST:ORZAX -1.41% 18 Other Stockholders Equity is ₺551 Mil as of Dec. 2025. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Orzaks Ilac Ve Kimyanayi Ticaret AS's Other Stockholders Equity for the quarter that ended in Dec. 2025 was ₺551 Mil.

Orzaks Ilac Ve Kimyanayi Ticaret AS's quarterly Other Stockholders Equity declined from Dec. 2023 (₺557 Mil) to Dec. 2024 (₺556 Mil) and declined from Dec. 2024 (₺556 Mil) to Dec. 2025 (₺551 Mil).

Orzaks Ilac Ve Kimyanayi Ticaret AS's annual Other Stockholders Equity declined from Dec. 2023 (₺557 Mil) to Dec. 2024 (₺556 Mil) and declined from Dec. 2024 (₺556 Mil) to Dec. 2025 (₺551 Mil).

Orzaks Ilac Ve Kimyanayi Ticaret AS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Orzaks Ilac Ve Kimyanayi Ticaret AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orzaks Ilac Ve Kimyanayi Ticaret AS Other Stockholders Equity Chart

Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend Dec23 Dec24 Dec25
Other Stockholders Equity
556.85 556.20 551.17

Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23 Dec24 Dec25
Other Stockholders Equity 556.85 556.20 551.17
IST:ORZAX
18GF Score
Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orzaks Ilac Ve Kimyanayi Ticaret AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₺551 Mil mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a Other Stockholders Equity of ₺551 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's Other Stockholders Equity too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current Other Stockholders Equity is ₺551 Mil. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's Other Stockholders Equity compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's Other Stockholders Equity of ₺551 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Consumer Packaged Goods company?
A good Other Stockholders Equity depends on the Consumer Packaged Goods industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. Orzaks Ilac Ve Kimyanayi Ticaret AS's current Other Stockholders Equity is ₺551 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current Other Stockholders Equity of ₺551 Mil. The current Other Stockholders Equity is ₺551 Mil. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current Other Stockholders Equity is ₺551 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orzaks Ilac Ve Kimyanayi Ticaret AS Business Description

Address Esentepe Mah, Buyukdere Cad, No:171, Metrocity Is Merkezi A Blok Kat:1, Sisli, Istanbul, TUR
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score

Get the complete analysis for IST:ORZAX

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺87.50
Price